MTHFR and hypertensive disorder: The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is thought to be a contributor to hcy and is associated with an increased risk of hypertension [13], with meta-analysis suggesting an increased risk of 24–87% [14].